Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain (Q34142832)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain |
scientific article |
Statements
1 reference
Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain (English)
1 reference
Christopher Janson
1 reference
Scott McPhee
1 reference
Larissa Bilaniuk
1 reference
John Haselgrove
1 reference
Mark Testaiuti
1 reference
Andrew Freese
1 reference
Dah-Jyuu Wang
1 reference
David Shera
1 reference
Peter Hurh
1 reference
Joan Rupin
1 reference
Elizabeth Saslow
1 reference
Olga Goldfarb
1 reference
Michael Goldberg
1 reference
Ghassem Larijani
1 reference
William Sharrar
1 reference
Larisa Liouterman
1 reference
Angelique Camp
1 reference
Edwin Kolodny
1 reference
Jude Samulski
1 reference
Paola Leone
1 reference
1 July 2002
1 reference
1 reference
13
1 reference
11
1 reference
1391-1412
1 reference
Identifiers
1 reference
1 reference